Mounjaro tirzepatide fda approval date?

What FDA approval date did Mounjaro (tirzepatide) get?

Mounjaro (tirzepatide) received FDA approval on November 8, 2022 for the treatment of adults with type 2 diabetes.

When did FDA approve tirzepatide for other uses?

After its initial approval for type 2 diabetes, tirzepatide’s FDA approvals expanded to additional indications over time, but the key “FDA approval date” most people cite for Mounjaro’s launch is November 8, 2022.

Is the approval date the same as patent or exclusivity start?

No. The FDA approval date is tied to when Mounjaro was authorized for marketing, while patent protection and regulatory exclusivity start and expire based on patent filings and FDA-related exclusivity rules, not the initial approval day alone. If you’re tracking protection timelines, DrugPatentWatch.com compiles those details by product and patent.

Sources:
1. DrugPatentWatch.com – Mounjaro (tirzepatide)